These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Caspofungin acetate for treatment of invasive fungal infections. Pacetti SA; Gelone SP Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942 [TBL] [Abstract][Full Text] [Related]
5. Caspofungin: first approved agent in a new class of antifungals. Johnson MD; Perfect JR Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003 [TBL] [Abstract][Full Text] [Related]
6. Caspofungin: the first representative of a new antifungal class. Letscher-Bru V; Herbrecht R J Antimicrob Chemother; 2003 Mar; 51(3):513-21. PubMed ID: 12615851 [TBL] [Abstract][Full Text] [Related]
7. Caspofungin acetate: an antifungal agent. Hoang A Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins]. Azanza JR; Montejo M Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():14-20. PubMed ID: 19572430 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin. Maschmeyer G; Glasmacher A Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202 [TBL] [Abstract][Full Text] [Related]
12. Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes. Song JC; Stevens DA Crit Rev Microbiol; 2016 Sep; 42(5):813-46. PubMed ID: 26369708 [TBL] [Abstract][Full Text] [Related]
13. Caspofungin: the first of a new class of antifungal agents. Valgus JM Cancer Pract; 2001; 9(6):314-6. PubMed ID: 11879335 [No Abstract] [Full Text] [Related]
14. Caspofungin in the treatment of invasive fungal infections. Keady S; Thacker M Intensive Crit Care Nurs; 2006 Feb; 22(1):59-62. PubMed ID: 16006127 [TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Sable CA; Nguyen BY; Chodakewitz JA; DiNubile MJ Transpl Infect Dis; 2002 Mar; 4(1):25-30. PubMed ID: 12123423 [TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of properties and clinical efficacy of the echinocandins. Kim R; Khachikian D; Reboli AC Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730 [TBL] [Abstract][Full Text] [Related]
17. Caspofungin: a major breakthrough in treatment of systemic fungal infections. Agarwal MB; Rathi SA; Ratho N; Subramanian R J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012 [TBL] [Abstract][Full Text] [Related]
18. Emerging echinocandins for treatment of invasive fungal infections. Turner MS; Drew RH; Perfect JR Expert Opin Emerg Drugs; 2006 May; 11(2):231-50. PubMed ID: 16634699 [TBL] [Abstract][Full Text] [Related]
19. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects]. Schäfer-Korting M Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850 [TBL] [Abstract][Full Text] [Related]
20. Echinocandins in the management of invasive fungal infections, Part 2. Morris MI; Villmann M Am J Health Syst Pharm; 2006 Oct; 63(19):1813-20. PubMed ID: 16990627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]